Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 07-Feb-2017

General Biotechnologies


General Biotechnologies identifies and develops undervalued innovation in the life sciences. Our flagship program — Nivien Therapeutics — is a venture-backed oncology platform.



Additional Questions

Investor questions have not yet been answered for this business